Is percutaneous interventional treatment for lung cancer considered minimally invasive? It is a minimally invasive surgery

Percutaneous interventional treatment for lung cancer, including percutaneous arterial infusion chemotherapy and percutaneous arterial embolization, is a minimally invasive surgery that has become the first-line standard treatment for lung cancer.

Lung cancer is one of the diseases with the fastest growing incidence and mortality, and is also the disease that poses the greatest threat to population health and life. So, is percutaneous interventional treatment of lung cancer considered minimally invasive?
Among all malignant tumors, the incidence and mortality of lung cancer in men worldwide ranks first, and the incidence and mortality of lung cancer in women ranks second. The traditional treatments for lung cancer are mainly surgery, radiotherapy and chemotherapy, but all of them have indications. In recent years, minimally invasive treatment of lung cancer has gradually been used in clinical practice.
Minimally invasive interventional methods for lung cancer are mainly transvascular and percutaneous. Transvascular is often referred to as bronchial artery infusion chemotherapy or bronchial artery embolization therapy. Percutaneous interventional therapy is minimally invasive and even better than surgical endoscopy. The puncture tool is just a needle, slightly thicker than a ballpoint pen refill, and the wound is very small. After a month, you can't even find the puncture point on the skin. And it does not require general anesthesia, which is suitable for more patients.
Percutaneous interventional treatment of lung cancer involves percutaneous puncture of the artery under local anesthesia, insertion of a catheter, finding the blood vessels supplying the tumor (usually the bronchial artery), injecting chemotherapy drugs through the catheter, and then using embolic agents to embolize the tumor blood vessels and block the blood supply to the tumor.